Literature DB >> 8922733

Selective labelling of bradykinin receptor subtypes in WI38 human lung fibroblasts.

S B Phagoo1, M Yaqoob, M C Brown, G M Burgess.   

Abstract

1. Binding of the B1 bradykinin receptor radioligand, [3H]-des-Arg10-kallidin (-KD) and the B2 receptor radioligand [3H]-bradykinin (-BK) was investigated in membranes prepared from WI38 human foetal lung fibroblasts. 2. One-site analysis of the saturation data for [3H]-des-Arg10-KD gave an equilibrium dissociation constant (KD) value of 0.51 +/- 0.12 nM and a maximum receptor density (Bmax) of 260 +/- 49 fmol mg-1 of protein. [3H]-des-Arg10-KD binding was displaced by ligands in the order: des-Arg10-KD > KD > > des-Arg9[Leu8]-BK > des-Arg9-BK > Hoe 140 > > BK, implying that it was binding selectively to B1 receptors. 3. One-site analysis of the binding of [3H]-BK to W138 membranes indicated that it had a KD value of 0.25 +/- 0.06 nM and a Bmax of 753 +/- 98 fmol mg-1 of protein. The potencies for displacement of [3H]-BK binding were: Hoe 140 > > BK = KD > > > des-Arg10-KD = des-Arg9[Leu8]-BK = des-Arg9-BK, which was consistent with binding to B2 receptors. 4. This is the first characterization of [3H]-des-Arg10-KD binding to include both kinetic and equilibrium data, and demonstrates that [3H]-des-Arg10-KD has a high affinity for human B1 bradykinin receptors and is sufficiently selective to be used as a radioligand for B1 receptors in human cells or tissues expressing an excess of B2 BK receptors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8922733      PMCID: PMC1915947          DOI: 10.1111/j.1476-5381.1996.tb15752.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  36 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Receptors for bradykinin in rabbit aortae.

Authors:  D Regoli; J Barabé; W K Park
Journal:  Can J Physiol Pharmacol       Date:  1977-08       Impact factor: 2.273

3.  Kinin receptors in experimental inflammation.

Authors:  F Marceau; J Barabé; S St-Pierre; D Regoli
Journal:  Can J Physiol Pharmacol       Date:  1980-05       Impact factor: 2.273

4.  Antagonists of bradykinin that stabilize a G-protein-uncoupled state of the B2 receptor act as inverse agonists in rat myometrial cells.

Authors:  L M Leeb-Lundberg; S A Mathis; M C Herzig
Journal:  J Biol Chem       Date:  1994-10-21       Impact factor: 5.157

5.  Ligand: a versatile computerized approach for characterization of ligand-binding systems.

Authors:  P J Munson; D Rodbard
Journal:  Anal Biochem       Date:  1980-09-01       Impact factor: 3.365

6.  Induction of B1 receptors in vivo in a model of persistent inflammatory mechanical hyperalgesia in the rat.

Authors:  A J Davis; M N Perkins
Journal:  Neuropharmacology       Date:  1994-01       Impact factor: 5.250

7.  Up-regulation of [3H]-des-Arg10-kallidin binding to the bradykinin B1 receptor by interleukin-1 beta in isolated smooth muscle cells: correlation with B1 agonist-induced PGI2 production.

Authors:  J P Galizzi; M C Bodinier; B Chapelain; S M Ly; L Coussy; S Giraud; G Neliat; T Jean
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

8.  Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies.

Authors:  F J Hock; K Wirth; U Albus; W Linz; H J Gerhards; G Wiemer; S Henke; G Breipohl; W König; J Knolle
Journal:  Br J Pharmacol       Date:  1991-03       Impact factor: 8.739

9.  Expression cloning of a human B1 bradykinin receptor.

Authors:  J G Menke; J A Borkowski; K K Bierilo; T MacNeil; A W Derrick; K A Schneck; R W Ransom; C D Strader; D L Linemeyer; J F Hess
Journal:  J Biol Chem       Date:  1994-08-26       Impact factor: 5.157

10.  Cloning and pharmacological characterization of a rabbit bradykinin B1 receptor.

Authors:  T MacNeil; K K Bierilo; J G Menke; J F Hess
Journal:  Biochim Biophys Acta       Date:  1995-11-07
View more
  2 in total

1.  Pharmacological characterization of the bradykinin B2 receptor: inter-species variability and dissociation between binding and functional responses.

Authors:  J L Paquet; J M Luccarini; C Fouchet; E Defrêne; B Loillier; C Robert; P Bélichard; B Cremers; D Pruneau
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

2.  Bradyzide, a potent non-peptide B(2) bradykinin receptor antagonist with long-lasting oral activity in animal models of inflammatory hyperalgesia.

Authors:  G M Burgess; M N Perkins; H P Rang; E A Campbell; M C Brown; P McIntyre; L Urban; E K Dziadulewicz; T J Ritchie; A Hallett; C R Snell; R Wrigglesworth; W Lee; C Davis; S B Phagoo; A J Davis; E Phillips; G S Drake; G A Hughes; A Dunstan; G C Bloomfield
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.